5-Jun-2026
Insider Shake-Up: ClearPoint Neuro Director Cashes Out a Chunk of Shares
TipRanks (Tue, 2-Jun 10:14 PM ET)
Lake Street Keeps Their Buy Rating on ClearPoint Neuro (CLPT)
TipRanks (Tue, 2-Jun 9:46 AM ET)
ACCESS Newswire (Wed, 27-May 4:30 PM ET)
ClearPoint Neuro Reports First Quarter 2026 Results
ACCESS Newswire (Wed, 13-May 4:05 PM ET)
ACCESS Newswire (Wed, 13-May 4:00 PM ET)
ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026
ACCESS Newswire (Wed, 29-Apr 4:05 PM ET)
ACCESS Newswire (Wed, 22-Apr 4:05 PM ET)
ACCESS Newswire (Mon, 20-Apr 4:05 PM ET)
Market Chameleon (Wed, 18-Mar 3:30 AM ET)
ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results
ACCESS Newswire (Tue, 17-Mar 4:05 PM ET)
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
Clearpoint Neuro trades on the NASDAQ stock market under the symbol CLPT.
As of June 5, 2026, CLPT stock price declined to $12.89 with 605,077 million shares trading.
CLPT has a beta of 3.03, meaning it tends to be more sensitive to market movements. CLPT has a correlation of 0.13 to the broad based SPY ETF.
CLPT has a market cap of $386.57 million. This is considered a Small Cap stock.
Last quarter Clearpoint Neuro reported $12 million in Revenue and -$.32 earnings per share. This beat revenue expectation by $104,664 and missed earnings estimates by -$.05.
In the last 3 years, CLPT traded as high as $30.10 and as low as $4.05.
The top ETF exchange traded funds that CLPT belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.
CLPT has underperformed the market in the last year with a return of +0.5%, while SPY returned +25.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in CLPT shares. However, CLPT has outperformed the market in the last 3 month and 2 week periods, returning +39.4% and +12.7%, while SPY returned +8.5% and -1.1%, respectively. This indicates CLPT has been having a stronger performance recently.
CLPT support price is $13.48 and resistance is $15.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CLPT shares will trade within this expected range on the day.
